Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder

Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder

Abstract Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by core impairments in social communication as well as restricted, repetitive patterns of behavior and/or interests. Individuals with ASD, which includes about 2% of the US population, have challenges with activit...

Full description

Bibliographic Details
Main Authors: Lauren M. Schmitt, Elizabeth G. Smith, Ernest V. Pedapati, Paul S. Horn, Meredith Will, Martine Lamy, Lillian Barber, Joe Trebley, Kevin Meyer, Mark Heiman, Korbin H. J. West, Phoevos Hughes, Sanjeev Ahuja, Craig A. Erickson
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-30909-0

Internet

https://doi.org/10.1038/s41598-023-30909-0

Similar Items